Atherosclerosis Monitoring and Atherogenicity Reduction Study

This study has been completed.

Sponsor:

Institute for Atherosclerosis Research, Russia

ClinicalTrials.gov Identifier:

NCT01734707

First Posted: November 28, 2012

Last Update Posted: November 28, 2012

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

This study was designed to estimate the effect of two-year treatment with time-released garlic-based drug Allicor on the progression of carotid atherosclerosis in double-blinded placebo-controlled randomized clinical trial.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.